The current state of peritoneal dialysis

Journal of the American Society of Nephrology

Volumn 27, Issue 11, 2016, Pages 3238-3252

  Mehrotra, Rajnish ^a,b   Devuyst, Olivier ^c,d   Davies, Simon J ^e   Johnson, David W ^f  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF ZURICH   (Switzerland)

^d UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

^e KEELE UNIVERSITY   (United Kingdom)

^f UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AQUAPORIN;

CARDIOMETABOLIC RISK; CARDIOVASCULAR RISK; END STAGE RENAL DISEASE; FLUID BALANCE; HEALTH CARE DELIVERY; HEALTH CARE UTILIZATION; HUMAN; KIDNEY FUNCTION; NONHUMAN; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; PRIORITY JOURNAL; PUBLIC POLICY; RENAL REPLACEMENT THERAPY; REVIEW; RISK ASSESSMENT; ADVERSE EFFECTS; CARDIOVASCULAR DISEASES; KIDNEY FAILURE, CHRONIC; PHYSIOLOGY; PROCEDURES; RISK FACTOR; TREATMENT OUTCOME; TRENDS;

CARDIOVASCULAR DISEASES; HUMANS; KIDNEY FAILURE, CHRONIC; PERITONEAL DIALYSIS; PERITONEUM; PERITONITIS; RISK FACTORS; TREATMENT OUTCOME;

EID: 85014083962     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2016010112     Document Type: Review

References (208)

1. Ganter G: Uber die Beseitigung giftiger Stoffe aus dem Blute durch Dialyse. Munch Med Wochenschr 70: 1478-1480, 1923
2. Wear JB, Sisk IR, Trinkle AJ: Peritoneal lavage in the treatment of uremia: an experimental and clinical study. J Urol 39: 53-62, 1938
3. Frank HA, Seligman AM, Fine J: Treatment of uremia after acute renal failure by peritoneal irrigation. J Am Med Assoc 130: 703-705, 1946
4. Seligman AM, Frank HA, Fine J: Treatment of Experimental Uremia by Means of Peritoneal Irrigation. J Clin Invest 25: 211-219, 1946
5. Frank HA, Seligman AM, Fine J: Further experiences with peritoneal irrigation for acuter renal failure including a description of modifications in method. Ann Surg 128: 561-608, 1948
6. Odel HM, Ferris DO, Power MH: Peritoneal lavage as an effective means of extrarenal excretion; a clinical appraisal. Am J Med 9: 63-77, 1950
7. Grollman A, Turner LB, McLEAN JA: Intermittent peritoneal lavage in nephrectomized dogs and its application to the human being. AMA Arch Intern Med 87: 379-390, 1951
8. Doolan PD, Murphy WP Jr, Wiggins RA, Carter NW, Cooper WC, Watten RH, Alpen EL: An evaluation of intermittent peritoneal lavage. Am J Med 26: 831-844, 1959
9. Maxwell MH, Rockney RE, Kleeman CR, Twiss MR: Peritoneal dialysis. 1. Technique and applications. J Am Med Assoc 170: 917-924, 1959.
10. Boen ST, Mulinari AS, Dillard DH, Scribner BH: Periodic peritoneal dialysis in the management of chronic uremia. Trans Am Soc Artif Intern Organs 8: 256-262, 1962
11. Tenckhoff H, SchechterH:A bacteriologically safe peritoneal access device. Trans Am Soc Artif Intern Organs 14: 181-187, 1968
12. Popovich RP, Moncrief JW, Decherd JB, Bomar JB, Pyle WK: The definition of a novel portable/wearable equilibrium peritoneal dialysis technique. Trans Am Soc Artif Intern Organs 5: 484-489, 1976
13. Oreopoulos DG, RobsonM, Izatt S, Clayton S, deVeber GA: A simple and safe technique for continuous ambulatory peritoneal dialysis (CAPD). Trans Am Soc Artif Intern Organs 24: 484-489, 1978
14. Maiorca R, Cantaluppi A, Cancarini GC, Scalamogna A, Broccoli R, Graziani G, Brasa S, Ponticelli C: Prospective controlled trial of a Y-connector and disinfectant to prevent peritonitis in continuous ambulatory peritoneal dialysis. Lancet 2: 642-644, 1983
15. Buoncristiani U: Birth and evolution of the "Y" set. ASAIO J 42: 8-11, 1996
16. Diaz-Buxo JA, Farmer CD, Walker PJ, Chandler JT, Holt KL: Continuous cyclic peritoneal dialysis: a preliminary report. Artif Organs 5: 157-161, 1981
17. Ahmad S, Gallagher N, Shen F: Intermittent peritoneal dialysis: status reassessed. Trans Am Soc Artif InternOrgans 25: 86-89, 1979
18. Heimbürger O, Waniewski J, Werynski A, Tranaeus A, Lindholm B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38: 495-506, 1990
19. Bloembergen WE, Port FK, Mauger EA, Wolfe RA: A comparison of mortality between patients treated with hemodialysis and peritoneal dialysis.JAmSocNephrol 6: 177-183, 1995
20. Mehrotra R: Peritoneal dialysis penetration in the United States: march toward the fringes? Perit Dial Int 26: 419-422, 2006
21. Jain AK, Blake P, Cordy P, Garg AX: Global trends in rates of peritoneal dialysis. J Am Soc Nephrol 23: 533-544, 2012
22. Mehrotra R, Kermah D, Fried L, Kalantar-Zadeh K, Khawar O, Norris K, Nissenson A: Chronic peritoneal dialysis in the United States: declining utilization despite improving outcomes. J Am Soc Nephrol 18: 2781-2788, 2007
23. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Bargman J, Vonesh E: Similar outcomes with hemodialysis and peritoneal dialysis in patients with end-stage renal disease. Arch Intern Med 171: 110-118, 2011
24. Chang YK, Hsu CC, Hwang SJ, Chen PC, Huang CC, Li TC, Sung FC: A comparative assessment of survival between propensity score-matched patients with peritoneal dialysis and hemodialysis in Taiwan. Medicine (Baltimore) 91: 144-151, 2012
25. Yeates K, Zhu N, Vonesh E, Trpeski L, Blake P, Fenton S: Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 27: 3568-3575, 2012
26. Heaf JG, Wehberg S: Relative survival of peritoneal dialysis and haemodialysis patients: effect of cohort and mode of dialysis initiation. PLoS One 9: e90119, 2014
27. Marshall MR, Polkinghorne KR, Kerr PG, Agar JW, Hawley CM, McDonald SP: Temporal Changes in Mortality Risk by Dialysis Modality in the Australian and New Zealand Dialysis Population. Am J Kidney Dis 66: 489-498, 2015
28. Ryu JH, Kim H, Kim KH, Hann HJ, Ahn HS, Lee S, Kim SJ, Kang DH, Choi KB, Ryu DR: Improving survival rate of Korean patients initiating dialysis. Yonsei Med J 56: 666-675, 2015
29. van de Luijtgaarden MW, Jager KJ, Segelmark M, Pascual J, Collart F, Hemke AC, Remon C, Metcalfe W, Miguel A, Kramar R, Aasarod K, Abu Hanna A, Krediet RT, Schon S, Ravani P, Caskey FJ,Couchoud C, Palsson R, Wanner C, Finne P, Noordzij M: Trends in dialysis modality choice and related patient survival in the ERA-EDTA Registry over a 20-year period. NephrolDial Transplant 31: 120-128, 2016
30. Quinn RR, Hux JE, Oliver MJ, Austin PC, Tonelli M, Laupacis A: Selection bias explains apparent differential mortality between dialysis modalities. J AmSoc Nephrol 22: 1534-1542, 2011
31. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ,CollinsAJ: Propensitymatched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21: 499-506, 2010
32. Mehrotra R, Chiu YW, Kalantar-Zadeh K, Vonesh E: The outcomes of continuous ambulatory and automated peritoneal dialysis are similar. Kidney Int 76: 97-107, 2009
33. Karopadi AN,MasonG, Rettore E, Ronco C: Cost of peritoneal dialysis and haemodialysis across the world. Nephrol Dial Transplant 28: 2553-2569, 2013
34. Nissenson AR, Prichard SS, Cheng IK, Gokal R, Kubota M, Maiorca R, Riella MC, Rottembourg J, Stewart JH: Non-medical factors that impact on ESRD modality selection. Kidney Int Suppl 40: S120-S127, 1993
35. Lameire N, Van Biesen W: Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 6: 75-82, 2010
36. Liu FX, Gao X, Inglese G, Chuengsaman P, Pecoits-Filho R, Yu A: A Global Overview of the Impact of Peritoneal Dialysis First or Favored Policies: An Opinion. Perit Dial Int 35: 406-420, 2015
37. Sedor JR, Watnick S, Patel UD, Cheung A, Harmon W, Himmelfarb J, Hostetter TH, Inrig JK,Mehrotra R, Robinson E, Smedberg PC, Shaffer RN; American Society of Nephrology ESRD Task Force: ASN End-Stage Renal Disease Task Force: perspective on prospective payments for renal dialysis facilities. J Am Soc Nephrol 21: 1235-1237, 2010
38. Watnick S, Weiner DE, Shaffer R, Inrig J, Moe S,Mehrotra R; Dialysis Advisory Group of the American Society of Nephrology: Comparing mandated health care reforms: the Affordable Care Act, accountable care organizations, and the Medicare ESRD program. Clin J Am Soc Nephrol 7: 1535-1543, 2012
39. Duong U, Kalantar-Zadeh K, Molnar MZ, Zaritsky JJ, Teitelbaum I, Kovesdy CP, Mehrotra R: Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients.AmJNephrol 35: 198-208, 2012
40. Tantivess S, Werayingyong P,Chuengsaman P, Teerawattananon Y: Universal coverage of renal dialysis in Thailand: promise, progress, and prospects. BMJ 346: f462, 2013
41. Blake PG, Golper TA, Saxena AB: A critical shortage of solution threatens unprecedented growth in peritoneal dialysis. Nephrol News Issues 28: 14-16, 2014
42. Mehrotra R, Marsh D, Vonesh E, Peters V, Nissenson A: Patient education and access of ESRD patients to renal replacement therapies beyond in-center hemodialysis. Kidney Int 68: 378-390, 2005
43. Kutner NG, Zhang R, Huang Y, Wasse H: Patient awareness and initiation of peritoneal dialysis. Arch Intern Med 171: 119-124, 2011
44. Manns BJ, Taub K, Vanderstraeten C, Jones H, Mills C, Visser M, McLaughlin K: The impact of education on chronic kidney disease patients' plans to initiate dialysis with self-care dialysis: a randomized trial. Kidney Int 68: 1777-1783, 2005
45. Lacson E Jr, Wang W, DeVries C, Leste K, Hakim RM, Lazarus M, Pulliam J: Effects of a nationwide predialysis educational program on modality choice, vascular access, and patient outcomes. Am J Kidney Dis 58: 235-242, 2011
46. Rioux JP, Cheema H, Bargman JM, Watson D, Chan CT: Effect of an in-hospital chronic kidney disease education program among patients with unplanned urgent-start dialysis. Clin J Am Soc Nephrol 6: 799-804, 2011
47. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G: Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis 32: 278-283, 1998
48. Lameire N, Van Biesen W: The pattern of referral of patients with end-stage renal disease to the nephrologist-a European survey. Nephrol Dial Transplant 14[Suppl 6]: 16-23, 1999
49. Song JH, Kim GA, Lee SW, Kim MJ: Clinical outcomes of immediate full-volume exchange one year after peritoneal catheter implantation for CAPD. Perit Dial Int 20: 194-199, 2000
50. Banli O, Altun H, Oztemel A: Early start of CAPD with the Seldinger technique. Perit Dial Int 25: 556-559, 2005
51. Povlsen JV, Ivarsen P: How to start the late referred ESRD patient urgently on chronic APD. Nephrol Dial Transplant 21[Suppl 2]: ii56-ii59, 2006
52. Jo YI, Shin SK, Lee JH, Song JO, Park JH: Immediate initiation of CAPD following percutaneous catheter placement without break-in procedure. Perit Dial Int 27: 179-183, 2007
53. Lobbedez T, Lecouf A, Ficheux M, Henri P, Hurault de Ligny B, Ryckelynck JP: Is rapid initiation of peritoneal dialysis feasible in unplanned dialysis patients? A single-centre experience. Nephrol Dial Transplant 23: 3290-3294, 2008
54. Yang YF, Wang HJ, Yeh CC, Lin HH, Huang CC: Early initiation of continuous ambulatory peritoneal dialysis in patients undergoing surgical implantation of Tenckhoff catheters. Perit Dial Int 31: 551-557, 2011
55. Ghaffari A: Urgent-start peritoneal dialysis: a quality improvement report. Am J Kidney Dis 59: 400-408, 2012
56. Koch M, Kohnle M, Trapp R, Haastert B, Rump LC, Aker S: Comparable outcome of acute unplanned peritoneal dialysis and haemodialysis. Nephrol Dial Transplant 27: 375-380, 2012
57. Alkatheeri AM, Blake PG, Gray D, Jain AK: Success of Urgent-Start Peritoneal Dialysis in a Large Canadian Renal Program. Perit Dial Int 36: 171-176, 2016
58. Mehrotra R: Expanding access to peritoneal dialysis for incident dialysis patients. Am J Kidney Dis 59: 330-332, 2012
59. Oliver MJ, Garg AX, Blake PG, Johnson JF, Verrelli M, Zacharias JM, Pandeya S, Quinn RR: Impact of contraindications, barriers to self-care and support on incident peritoneal dialysis utilization. Nephrol Dial Transplant 25: 2737-2744, 2010
60. Cheng CH, Shu KH, Chuang YW, Huang ST, Chou MC, Chang HR: Clinical outcome of elderly peritoneal dialysis patients with assisted care in a single medical centre: a 25 year experience. Nephrology (Carlton) 18: 468-473, 2013
61. Lobbedez T, VergerC, Ryckelynck JP, Fabre E, Evans D: Is assisted peritoneal dialysis associated with technique survival when competing events are considered? Clin J Am Soc Nephrol 7: 612-618, 2012
62. Béchade C, Lobbedez T, Ivarsen P, Povlsen JV: Assisted Peritoneal Dialysis for Older People with End-Stage Renal Disease: The French andDanish Experience. Perit Dial Int 35: 663-666, 2015
63. Oliver MJ, Quinn RR, Richardson EP, Kiss AJ, Lamping DL, Manns BJ: Home care assistance and the utilization of peritoneal dialysis. Kidney Int 71: 673-678, 2007
64. Verger C, Duman M, Durand PY, Veniez G, Fabre E, Ryckelynck JP: Influence of autonomy and type of home assistance on the prevention of peritonitis in assisted automated peritoneal dialysis patients. An analysis of data from the French Language Peritoneal Dialysis Registry. Nephrol Dial Transplant 22: 1218-1223, 2007
65. Iyasere OU, Brown EA, Johansson L, Huson L, Smee J, Maxwell AP, Farrington K, Davenport A: Quality of Life and Physical Function in Older Patients on Dialysis: A Comparison of Assisted Peritoneal Dialysis with Hemodialysis. Clin J Am Soc Nephrol 11: 423-430, 2015
66. Mehrotra R, Soohoo M, Rivara MB, Himmelfarb J, Cheung AK, Arah OA, NissensonAR, RavelV, Streja E,Kuttykrishnan S, Katz R, Molnar MZ, Kalantar-Zadeh K: Racial and Ethnic Disparities in Use of and Outcomes with Home Dialysis in the United States [published online ahead of print December 10, 2015]. J Am Soc Nephrol doi: 10.1681/ASN.2015050472
67. Brimble KS, Walker M, Margetts PJ, Kundhal KK, Rabbat CG: Meta-analysis: peritoneal membrane transport, mortality, and technique failure in peritoneal dialysis. J Am Soc Nephrol 17: 2591-2598, 2006
68. Mehrotra R, Ravel V, Streja E, Kuttykrishnan S, Adams SV, Katz R, Molnar MZ, Kalantar-Zadeh K: Peritoneal Equilibration Test and Patient Outcomes. Clin J Am Soc Nephrol 10: 1990-2001, 2015
69. Devuyst O, Nielsen S, Cosyns JP, Smith BL, Agre P, Squifflet JP, Pouthier D, Goffin E: Aquaporin-1 and endothelial nitric oxide synthase expression in capillary endothelia of human peritoneum. Am J Physiol 275: H234-H242, 1998
70. Agre P: Aquaporin water channels (Nobel Lecture). Angew Chem Int Ed Engl 43: 4278-4290, 2004
71. Morelle J, Sow A, Vertommen D, Jamar F, Rippe B, Devuyst O: Quantification of osmotic water transport in vivo using fluorescent albumin. Am J Physiol Renal Physiol 307: F981-F989, 2014
72. Ni J, Verbavatz JM, Rippe A, Boisdé I, Moulin P, Rippe B, Verkman AS, Devuyst O: Aquaporin-1 plays an essential role in water permeability and ultrafiltration during peritoneal dialysis. Kidney Int 69: 1518-1525, 2006
73. Rippe B, Stelin G, Haraldsson B: Computer simulations of peritoneal fluid transport in CAPD. Kidney Int 40: 315-325, 1991
74. Stoenoiu MS, Ni J, Verkaeren C, Debaix H, Jonas JC, Lameire N, Verbavatz JM, Devuyst O: Corticosteroids induce expression of aquaporin-1 and increase transcellular water transport in rat peritoneum. J Am Soc Nephrol 14: 555-565, 2003
75. de Arteaga J, Ledesma F, Garay G, Chiurchiu C, de la Fuente J, Douthat W, Massari P, Terryn S, Devuyst O: High-dose steroid treatment increases free water transport in peritoneal dialysis patients. NephrolDial Transplant 26: 4142-4145, 2011
76. Yool AJ,Morelle J, Cnops Y, Verbavatz JM, Campbell EM, Beckett EA, Booker GW, Flynn G, Devuyst O: AqF026 is a pharmacologic agonist of the water channel aquaporin-1. J Am SocNephrol 24: 1045-1052, 2013
77. Oh KH, Jung JY, Yoon MO, Song A, Lee H, Ro H, Hwang YH, Kim DK, Margetts P, Ahn C: Intra-peritoneal interleukin-6 system is a potent determinant of the baseline peritoneal solute transport in incident peritoneal dialysis patients. Nephrol Dial Transplant 25: 1639-1646, 2010
78. Pecoits-Filho R, Araújo MR, Lindholm B, Stenvinkel P, Abensur H, Romão JE Jr, Marcondes M, De Oliveira AH, Noronha IL: Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17: 1480-1486, 2002
79. LambieM,Chess J, Donovan KL, KimYL, Do JY, Lee HB, Noh H, Williams PF, Williams AJ, Davison S, Dorval M, Summers A, Williams JD, Bankart J, Davies SJ, Topley N; Global Fluid Study Investigators: Independent effects of systemic and peritoneal inflammation on peritoneal dialysis survival. J Am Soc Nephrol 24: 2071-2080, 2013
80. Rumpsfeld M, McDonald SP, Johnson DW: Higher peritoneal transport status is associated with higher mortality and technique failure in the Australian and New Zealand peritoneal dialysis patient populations. J Am Soc Nephrol 17: 271-278, 2006
81. Gillerot G, Goffin E, MichelC, Evenepoel P, Biesen WV, Tintillier M, Stenvinkel P, Heimbürger O, Lindholm B, Nordfors L, Robert A, Devuyst O: Genetic and clinical factors influence the baseline permeability of the peritoneal membrane. Kidney Int 67: 2477-2487, 2005
82. Hwang YH, Son MJ, Yang J, Kim K, Chung W, Joo KW, Kim Y, Ahn C, Oh KH: Effects of interleukin-6 T15A single nucleotide polymorphism on baseline peritoneal solute transport rate in incident peritoneal dialysis patients. Perit Dial Int 29: 81-88, 2009
83. Combet S, Van Landschoot M, Moulin P, Piech A, Verbavatz JM, Goffin E, Balligand JL, Lameire N, Devuyst O: Regulation of aquaporin-1 and nitric oxide synthase isoforms in a rat model of acute peritonitis. J Am Soc Nephrol 10: 2185-2196, 1999
84. Ferrier ML, Combet S, van Landschoot M, Stoenoiu MS, Cnops Y, Lameire N, Devuyst O: Inhibition of nitric oxide synthase reverses changes in peritoneal permeability in a rat model of acute peritonitis. Kidney Int 60: 2343-2350, 2001
85. Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O: Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol 14: 3205-3216, 2003
86. Ni J, McLoughlin RM, Brodovitch A, Moulin P, Brouckaert P, Casadei B, FeronO, Topley N, Balligand JL, Devuyst O: Nitric oxide synthase isoforms play distinct roles during acute peritonitis. Nephrol Dial Transplant 25: 86-96, 2010
87. Devuyst O, Margetts PJ, Topley N: The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 21: 1077-1085, 2010
88. Morelle J, Sow A, Hautem N, Bouzin C, Crott R, Devuyst O, Goffin E: Interstitial Fibrosis Restricts Osmotic Water Transport in Encapsulating Peritoneal Sclerosis. J Am Soc Nephrol 26: 2521-2533, 2015
89. Korte MR, Sampimon DE, Betjes MG, Krediet RT: Encapsulating peritoneal sclerosis: the state of affairs. Nat Rev Nephrol 7: 528-538, 2011
90. Lambie ML, John B, Mushahar L, Huckvale C, Davies SJ: The peritoneal osmotic conductance is low well before the diagnosis of encapsulating peritoneal sclerosis is made. Kidney Int 78: 611-618, 2010
91. Sampimon DE, Barreto DL, Coester AM, Struijk DG, Krediet RT: The value of osmotic conductance and free water transport in the prediction of encapsulating peritoneal sclerosis. Adv Perit Dial 30: 21-26, 2014
92. Williams JD, Craig KJ, TopleyN, Von Ruhland C, Fallon M, Newman GR, Mackenzie RK, Williams GT; Peritoneal Biopsy Study Group: Morphologic changes in the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 13: 470-479, 2002
93. Yang AH, Chen JY, Lin JK: Myofibroblastic conversion of mesothelial cells. Kidney Int 63: 1530-1539, 2003
94. Yáñez-MóM, Lara-Pezzi E, Selgas R, Ramírez-Huesca M, Domínguez-Jiménez C, Jiménez-Heffernan JA, Aguilera A, Sánchez-Tomero JA, Bajo MA, Alvarez V, Castro MA, del Peso G, Cirujeda A, Gamallo C, Sánchez-Madrid F, López-Cabrera M: Peritoneal dialysis and epithelial-to-mesenchymal transition of mesothelial cells.NEngl J Med 348: 403-413, 2003
95. Margetts PJ, Bonniaud P, Liu L, Hoff CM, Holmes CJ, West-Mays JA, Kelly MM: Transient overexpression of TGF-beta1 induces epithelial mesenchymal transition in the rodent peritoneum. J Am Soc Nephrol 16: 425-436, 2005
96. Aroeira LS, Aguilera A, Selgas R, Ramírez-Huesca M, Pérez-Lozano ML, Cirugeda A, Bajo MA, del Peso G, Sánchez-Tomero JA, Jiménez-Heffernan JA, López-Cabrera M: Mesenchymal conversion of mesothelial cells as a mechanism responsible for high solute transport rate in peritoneal dialysis: role of vascular endothelial growth factor. AmJ Kidney Dis 46: 938-948, 2005
97. Humphreys BD, Lin SL, Kobayashi A, Hudson TE, Nowlin BT, Bonventre JV, ValeriusMT,McMahon AP,Duffield JS: Fate tracing reveals the pericyte and not epithelial origin of myofibroblasts in kidney fibrosis. Am J Pathol 176: 85-97, 2010
98. Kriz W, Kaissling B, Le Hir M: Epithelialmesenchymal transition (EMT) in kidney fibrosis: fact or fantasy? J Clin Invest 121: 468-474, 2011
99. Quaggin SE, Kapus A: Scar wars: mapping the fate of epithelial-mesenchymalmyofibroblast transition. Kidney Int 80: 41-50, 2011
100. Chen YT, Chang YT, Pan SY, Chou YH, Chang FC, Yeh PY, Liu YH, Chiang WC, Chen YM, Wu KD, Tsai TJ, Duffield JS, Lin SL: Lineage tracing reveals distinctive fates for mesothelial cells and submesothelial fibroblasts during peritoneal injury. JAmSoc Nephrol 25: 2847-2858, 2014
101. García-López E, Lindholm B, Davies S: An update on peritoneal dialysis solutions. Nat Rev Nephrol 8: 224-233, 2012
102. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi MG, Tan SH, Voss D; balANZ Trial Investigators: The effect of low glucose degradation product, neutral pH versus standard peritoneal dialysis solutions on peritoneal membrane function: the bal-ANZ trial. Nephrol Dial Transplant 27: 4445-4453, 2012
103. Kolesnyk I, Noordzij M, Dekker FW, Boeschoten EW, Krediet RT: A positive effect of AII inhibitors on peritoneal membrane function in long-term PD patients. Nephrol Dial Transplant 24: 272-277, 2009
104. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister K, Wiggins KJ: Association of dialysis modality and cardiovascular mortality in incident dialysis patients. Clin J Am Soc Nephrol 4: 1620-1628, 2009
105. Isoyama N, Machowska A, Qureshi AR, Yamamoto T, Anderstam B, Heimburger O, Barany P, Stenvinkel P, Lindholm B: Elevated Circulating S100a12 Associates with Vascular Disease and Worse Clinical Outcome in Peritoneal Dialysis Patients. Perit Dial Int 36: 269-276, 2015
106. Boudville N, Kemp A, Clayton P, Lim W, Badve SV, Hawley CM, McDonald SP, Wiggins KJ, Bannister KM, Brown FG, Johnson DW: Recent peritonitis associates with mortality among patients treated with peritoneal dialysis. J Am Soc Nephrol 23: 1398-1405, 2012
107. Davies SJ, Phillips L, Griffiths AM, Russell LH, Naish PF, Russell GI: What really happens to people on long-term peritoneal dialysis? Kidney Int 54: 2207-2217, 1998
108. Kim H, Kim KH, Ahn SV, Kang SW, Yoo TH, Ahn HS, Hann HJ, Lee S, Ryu JH, Yu M, Kim SJ, Kang DH, Choi KB, Ryu DR: Risk of major cardiovascular events among incident dialysis patients: A Korean national population-based study. Int J Cardiol 198: 95-101, 2015
109. Wang AY, Brimble KS, Brunier G, Holt SG, Jha V, Johnson DW, Kang SW, Kooman JP, LambieM, McIntyre C, Mehrotra R, Pecoits-Filho R: ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part I - Assessment and Management of Various Cardiovascular Risk Factors. Perit Dial Int 35: 379-387, 2015
110. Wang AY, Brimble KS, Brunier G, Holt SG, Jha V, Johnson DW, Kang SW, Kooman JP, LambieM, McIntyre C,Mehrotra R, Pecoits-Filho R: ISPD Cardiovascular and Metabolic Guidelines in Adult Peritoneal Dialysis Patients Part II - Management of Various Cardiovascular Complications. Perit Dial Int 35: 388-396, 2015
111. Little J, Phillips L, Russell L, Griffiths A, Russell GI, Davies SJ: Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J AmSocNephrol 9: 1931-1939, 1998
112. Attman PO, Samuelsson OG, Moberly J, Johansson AC, Ljungman S, Weiss LG, Knight-Gibson C, Alaupovic P: Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Kidney Int 55: 1536-1542, 1999
113. de Moraes TP, Fortes PC, Ribeiro SC, Riella MC, Pecoits-Filho R: Comparative analysis of lipid and glucose metabolismbiomarkers in non-diabetic hemodialysis and peritoneal dialysis patients. J BrasNefrol 33: 173-179, 2011.
114. Johnson DW, Armstrong K, Campbell SB, Mudge DW, Hawley CM, Coombes JS, Prins JB, Isbel NM: Metabolic syndrome in severe chronic kidney disease: Prevalence, predictors, prognostic significance and effects of risk factor modification. Nephrology (Carlton) 12: 391-398, 2007
115. Jiang N, Qian J, Lin A, Lindholm B, Axelsson J, Yao Q: Initiation of glucosebased peritoneal dialysis is associated with increased prevalence of metabolic syndrome in non-diabetic patients with endstage renal disease. Blood Purif 26: 423-428, 2008
116. Szeto CC, Chow KM, Kwan BC, Chung KY, Leung CB, Li PK: New-onset hyperglycemia in nondiabetic chinese patients started on peritoneal dialysis. Am J Kidney Dis 49: 524-532, 2007
117. Choi SJ, Kim NR, Hong SA, Lee WB, Park MY, KimJK, Hwang SD, Lee HK: Changes in body fat mass in patients after starting peritoneal dialysis. Perit Dial Int 31: 67-73, 2011
118. Lievense H, Kalantar-Zadeh K, Lukowsky LR, Molnar MZ, Duong U, Nissenson A, Krishnan M, Krediet R, Mehrotra R: Relationship of body size and initial dialysis modality on subsequent transplantation, mortality and weight gain of ESRD patients. Nephrol Dial Transplant 27: 3631-3638, 2012
119. Ahmadi SF, Zahmatkesh G, Streja E, Mehrotra R, Rhee CM, Kovesdy CP, Gillen DL, Ahmadi E, Fonarow GC, Kalantar-Zadeh K: Association of Body Mass Index with Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis. Perit Dial Int 36: 315-325, 2016
120. Bergström J, Fürst P, Alvestrand A, Lindholm B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44: 1048-1057, 1993
121. Park J, Ahmadi SF, Streja E, Molnar MZ, Flegal KM, Gillen D, Kovesdy CP, Kalantar-Zadeh K: Obesity paradox in end-stage kidney disease patients. Prog Cardiovasc Dis 56: 415-425, 2014.
122. McDonald SP, Collins JF, Johnson DW: Obesity is associated with worse peritoneal dialysis outcomes in the Australia and New Zealand patient populations. J Am Soc Nephrol 14: 2894-2901, 2003
123. Fernandes NM, Bastos MG, Franco MR, Chaoubah A, Lima MG, Divino-Filho JC, Qureshi AR; Brazilian Peritoneal Dialysis Multicenter Study (BRAZPD) Group: Body size and longitudinal body weight changes do not increase mortality in incident peritoneal dialysis patients of the Brazilian peritoneal dialysis multicenter study. Clinics (Sao Paulo) 68: 51-58, 2013
124. Badve SV, Paul SK, Klein K, Clayton PA, Hawley CM, Brown FG, Boudville N, Polkinghorne KR, McDonald SP, Johnson DW: The association between body mass index and mortality in incident dialysis patients. PLoS One 9: e114897, 2014
125. LiaoCT,KaoTW,ChouYH,WuMS,Chen YM, Chuang HF, Hung KY, Chu TS, Wu KD, Tsai TJ: Associations of metabolic syndrome and its components with cardiovascular outcomes among non-diabetic patients undergoing maintenance peritoneal dialysis. NephrolDial Transplant 26: 4047-4054, 2011
126. Szeto CC, Kwan BC, Chow KM, Leung CB, Cheng MS, Law MC, Li PK: Metabolic syndrome in peritoneal dialysis patients: choice of diagnostic criteria and prognostic implications. Clin J AmSocNephrol 9: 779-787, 2014
127. Chou CY, Liang CC, Kuo HL, Chang CT, Liu JH, Lin HH, Wang IK, Yang YF, Huang CC: Comparing risk of new onset diabetes mellitus in chronic kidney disease patients receiving peritoneal dialysis and hemodialysis using propensity score matching. PLoS One 9: e87891, 2014
128. Woodward RS, Schnitzler MA, Baty J, Lowell JA, Lopez-Rocafort L, Haider S, Woodworth TG, Brennan DC: Incidence and cost of new onset diabetes mellitus among U.S. wait-listed and transplanted renal allograft recipients. Am J Transplant 3: 590-598, 2003
129. Davies SJ,WoodrowG, Donovan K, PlumJ, Williams P, Johansson AC, Bosselmann HP, Heimbürger O, Simonsen O, Davenport A, Tranaeus A, Divino Filho JC: Icodextrin improves the fluid status of peritoneal dialysis patients: results of a double-blind randomized controlled trial. J Am Soc Nephrol 14: 2338-2344, 2003
130. Wolfson M, Piraino B, Hamburger RJ, Morton AR; Icodextrin Study Group: A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis. Am J Kidney Dis 40: 1055-1065, 2002
131. de Moraes TP, Andreoli MC, Canziani ME, da Silva DR, Caramori JC, Ponce D, Cassi HV, de Andrade Bastos K, RioDR, Pinto SW, Filho SR, de Campos LG, Olandoski M, Divino-Filho JC, Pecoits-Filho R: Icodextrin reduces insulin resistance in non-diabetic patients undergoing automated peritoneal dialysis: results of a randomized controlled trial (STARCH). Nephrol Dial Transplant 30: 1905-1911, 2015
132. Paniagua R, Ventura MD, Avila-Díaz M, Cisneros A, Vicenté-Martínez M, Furlong MD, García-González Z, Villanueva D, Orihuela O, Prado-Uribe MD, Alcántara G, Amato D: Icodextrin improves metabolic and fluid management in high and highaverage transport diabetic patients. Perit Dial Int 29: 422-432, 2009
133. Li PK, Culleton BF, Ariza A, Do JY, Johnson DW, Sanabria M, Shockley TR, Story K, Vatazin A, Verrelli M, Yu AW, Bargman JM; IMPENDIA and EDEN Study Groups: Randomized, controlled trial of glucose-sparing peritoneal dialysis in diabetic patients.JAm Soc Nephrol 24: 1889-1900, 2013
134. Sniderman AD, Sloand JA, Li PK, Story K, Bargman JM: Influence of low-glucose peritoneal dialysis on serum lipids and apolipoproteins in the IMPENDIA/EDEN trials. J Clin Lipidol 8: 441-447, 2014
135. Duong U, Mehrotra R, Molnar MZ, Noori N, Kovesdy CP, Nissenson AR, Kalantar-Zadeh K: Glycemic control and survival in peritoneal dialysis patients with diabetesmellitus. Clin J Am Soc Nephrol 6: 1041-1048, 2011
136. Yoo DE, Park JT, Oh HJ, Kim SJ, Lee MJ, Shin DH, Han SH, Yoo TH, Choi KH, Kang SW: Good glycemic control is associated with better survival in diabetic patients on peritoneal dialysis: a prospective observational study. PLoS One 7: e30072, 2012
137. Palmer SC, Navaneethan SD, Craig JC, Johnson DW, Perkovic V, Nigwekar SU, Hegbrant J, Strippoli GF: HMG CoA reductase inhibitors (statins) for dialysis patients. Cochrane Database Syst Rev 9: CD004289, 2013
138. Baigent C, Landray MJ, Reith C, Emberson J,WheelerDC, Tomson C,WannerC, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators: The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebocontrolled trial. Lancet 377: 2181-2192, 2011
139. Bargman JM, Thorpe KE, Churchill DN; CANUSA Peritoneal Dialysis Study Group: Relative contribution of residual renal function and peritoneal clearance to adequacy of dialysis: a reanalysis of the CANUSA study. J Am Soc Nephrol 12: 2158-2162, 2001
140. Termorshuizen F, Dekker FW, van Manen JG, Korevaar JC, Boeschoten EW, Krediet RT; NECOSAD Study Group: Relative contribution of residual renal function and different measures of adequacy to survival in hemodialysis patients: an analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis (NECOSAD)-2. J Am Soc Nephrol 15: 1061-1070, 2004
141. Fernández-Lucas M, Teruel-Briones JL, Gomis-Couto A, Villacorta-Pérez J,Quereda-Rodríguez-Navarro C: Maintaining residual renal function in patients on haemodialysis: 5-year experience using a progressively increasing dialysis regimen. Nefrologia 32: 767-776, 2012
142. Lin YF, Huang JW, Wu MS, Chu TS, Lin SL, Chen YM, Tsai TJ, Wu KD: Comparison of residual renal function in patients undergoing twice-weekly versus three-timesweekly haemodialysis. Nephrology (Carlton) 14: 59-64, 2009
143. Seo EY, An SH, Cho JH, Suh HS, Park SH, Gwak H, Kim YL, Ha H: Effect of biocompatible peritoneal dialysis solution on residual renal function: a systematic review of randomized controlled trials. Perit Dial Int 34: 724-731, 2014
144. Kjaergaard KD, Peters CD, Jespersen B, Tietze IN, Madsen JK, Pedersen BB, Novosel MK, Laursen KS, Bibby BM, Strandhave C, Jensen JD: Angiotensin blockade and progressive loss of kidney function in hemodialysis patients: a randomized controlled trial. Am J Kidney Dis 64: 892-901, 2014
145. Jansen MA, Hart AA, Korevaar JC, Dekker FW, Boeschoten EW, Krediet RT; NECOSAD Study Group: Predictors of the rate of decline of residual renal function in incident dialysis patients. Kidney Int 62: 1046-1053, 2002
146. Moist LM, Port FK, Orzol SM, Young EW, Ostbye T, Wolfe RA, Hulbert-Shearon T, Jones CA, Bloembergen WE: Predictors of loss of residual renal function among new dialysis patients. J Am Soc Nephrol 11: 556-564, 2000
147. van Biesen W, Claes K, Covic A, Fan S, Lichodziejewska-Niemierko M, Schoder V, Verger C, Wabel P: A multicentric, international matched pair analysis of body composition in peritoneal dialysis versus haemodialysis patients. Nephrol Dial Transplant 28: 2620-2628, 2013
148. Ha IS, Yap HK, Munarriz RL, Zambrano PH, Flynn JT, Bilge I, Szczepanska M, Lai WM, Antonio ZL, Gulati A, HoomanN, vanHoeck K, Higuita LM, Verrina E, Klaus G, Fischbach M, Riyami MA, Sahpazova E, Sander A, Warady BA, Schaefer F; International Pediatric Peritoneal Dialysis Network Registry: Risk factors for loss of residual renal function in children treated with chronic peritoneal dialysis. Kidney Int 88: 605-613, 2015
149. Medcalf JF, Harris KP, Walls J: Role of diuretics in the preservation of residual renal function in patients on continuous ambulatory peritoneal dialysis. Kidney Int 59: 1128-1133, 2001
150. Johnson DW, Brown FG, Clarke M, Boudville N, Elias TJ, Foo MW, Jones B, Kulkarni H, Langham R, Ranganathan D, Schollum J, Suranyi M, Tan SH, Voss D; balANZ Trial Investigators: Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes. J AmSocNephrol 23: 1097-1107, 2012
151. Cho Y, Johnson DW, Craig JC, Strippoli GF, Badve SV, Wiggins KJ: Biocompatible dialysis fluids for peritoneal dialysis. Cochrane Database Syst Rev 3: CD007554, 2014
152. Udayaraj UP, Steenkamp R, Caskey FJ, Rogers C, Nitsch D, Ansell D, Tomson CR: Blood pressure and mortality risk on peritoneal dialysis. AmJ Kidney Dis 53: 70-78, 2009
153. Davies SJ, Davenport A: The role of bioimpedance and biomarkers in helping to aid clinical decision-making of volume assessments in dialysis patients. Kidney Int 86: 489-496, 2014
154. Brown EA, Davies SJ, Rutherford P, Meeus F, Borras M, Riegel W, Divino Filho JC, Vonesh E, van Bree M; EAPOS Group: Survival of functionally anuric patients on automated peritoneal dialysis: the European APDOutcome Study. J AmSoc Nephrol 14: 2948-2957, 2003
155. Jansen MA, Termorshuizen F, Korevaar JC, Dekker FW, Boeschoten E, Krediet RT; NECOSAD Study Group: Predictors of survival in anuric peritoneal dialysis patients. Kidney Int 68: 1199-1205, 2005
156. Johnson DW, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Badve SV: Superior survival of high transporters treated with automated versus continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant 25: 1973-1979, 2010
157. Cho Y, Johnson DW, Badve S, Craig JC, Strippoli GF, Wiggins KJ: Impact of icodextrin on clinical outcomes in peritoneal dialysis: a systematic review of randomized controlled trials. Nephrol Dial Transplant 28: 1899-1907, 2013
158. Mehrotra R, Duong U, Jiwakanon S, Kovesdy CP, Moran J, Kopple JD, Kalantar-Zadeh K: Serum albumin as a predictor of mortality in peritoneal dialysis: comparisons with hemodialysis. Am J Kidney Dis 58: 418-428, 2011
159. John B, Tan BK, Dainty S, Spanel P, Smith D, Davies SJ: Plasma volume, albumin, and fluid status in peritoneal dialysis patients. Clin J Am Soc Nephrol 5: 1463-1470, 2010
160. Tan BK, Yu Z, Fang W, Lin A, Ni Z, Qian J, Woodrow G, Jenkins SB, Wilkie ME, Davies SJ: Longitudinal bioimpedance vector plots add little value to fluid management of peritoneal dialysis patients. Kidney Int 89: 487-497, 2016
161. Cho Y, Johnson DW: Peritoneal dialysisrelated peritonitis: towards improving evidence, practices, and outcomes. Am J Kidney Dis 64: 278-289, 2014
162. Johnson DW, Dent H, Hawley CM, McDonald SP, Rosman JB, Brown FG, Bannister KM, Wiggins KJ: Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis 53: 290-297, 2009
163. Szeto CC, Wong TY, Chow KM, Leung CB, Li PK: The clinical course of culture-negative peritonitis complicating peritoneal dialysis. Am J Kidney Dis 42: 567-574, 2003
164. Szeto CC, Chow KM, Kwan BC, Law MC, Chung KY, Yu S, Leung CB, Li PK: Staphylococcus aureus peritonitis complicates peritoneal dialysis: review of 245 consecutive cases. Clin J Am Soc Nephrol 2: 245-251, 2007
165. Szeto CC, Kwan BC, Chow KM, LauMF, Law MC, Chung KY, Leung CB, Li PK: Coagulase negative staphylococcal peritonitis in peritoneal dialysis patients: review of 232 consecutive cases. Clin J Am Soc Nephrol 3: 91-97, 2008
166. Barraclough K, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Corynebacterium peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 82 cases. Nephrol Dial Transplant 24: 3834-3839, 2009
167. FahimM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Culture-negative peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes in 435 cases. Am J Kidney Dis 55: 690-697, 2010
168. Miles R, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int 76: 622-628, 2009
169. Barraclough K, Hawley CM,McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Polymicrobial peritonitis in peritoneal dialysis patients in Australia: predictors, treatment, and outcomes. Am J Kidney Dis 55: 121-131, 2010
170. Edey M, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Enterococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 116 cases. Nephrol Dial Transplant 25: 1272-1278, 2010
171. FahimM, Hawley CM,McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Coagulase-negative staphylococcal peritonitis in Australian peritoneal dialysis patients: predictors, treatment and outcomes in 936 cases. Nephrol Dial Transplant 25: 3386-3392, 2010
172. Govindarajulu S, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Staphylococcus aureus peritonitis in Australian peritoneal dialysis patients: predictors, treatment, and outcomes in 503 cases. Perit Dial Int 30: 311-319, 2010
173. Jarvis EM, Hawley CM, McDonald SP, Brown FG, Rosman JB, Wiggins KJ, Bannister KM, Johnson DW: Predictors, treatment, and outcomes of non-Pseudomonas Gram-negative peritonitis. Kidney Int 78: 408-414, 2010
174. Ghali JR, Bannister KM, Brown FG, Rosman JB, Wiggins KJ, Johnson DW, McDonald SP: Microbiology and outcomes of peritonitis in Australian peritoneal dialysis patients. Perit Dial Int 31: 651-662, 2011
175. BrownMC, Simpson K, Kerssens JJ,Mactier RA; Scottish Renal Registry: Encapsulating peritoneal sclerosis in the new millennium: a national cohort study. Clin J Am Soc Nephrol 4: 1222-1229, 2009
176. Johnson DW, Cho Y, Livingston BE, Hawley CM, McDonald SP, Brown FG, Rosman JB, Bannister KM, Wiggins KJ: Encapsulating peritoneal sclerosis: incidence, predictors, and outcomes. Kidney Int 77: 904-912, 2010
177. Howard K, Hayes A, Cho Y, Cass A, Clarke M, Johnson DW: Economic evaluation of neutral-pH, low-glucose degradation product peritoneal dialysis solutions compared with standard solutions: a secondary analysis of the balANZ Trial. Am J Kidney Dis 65: 773-779, 2015
178. Morton RL, Snelling P, Webster AC, Rose J, Masterson R, Johnson DW, Howard K: Dialysis modality preference of patients with CKD and family caregivers: a discretechoice study.AmJ KidneyDis 60: 102-111, 2012
179. Campbell DJ, Johnson DW, Mudge DW, Gallagher MP, Craig JC: Prevention of peritoneal dialysis-related infections. Nephrol Dial Transplant 30: 1461-1472, 2015
180. Huang JW, Hung KY, Yen CJ, Wu KD, Tsai TJ: Comparison of infectious complications in peritoneal dialysis patients using either a twin-bag system or automated peritoneal dialysis. Nephrol Dial Transplant 16: 604-607, 2001
181. Han SH, Lee SC, Ahn SV, Lee JE, Choi HY, Kim BS, Kang SW, Choi KH, Han DS, Lee HY: Improving outcome of CAPD: twentyfive years' experience in a single Korean center. Perit Dial Int 27: 432-440, 2007
182. Moraes TP, Pecoits-Filho R, Ribeiro SC, Rigo M, Silva MM, Teixeira PS, Pasqual DD, Fuerbringer R, RiellaMC: Peritoneal dialysis in Brazil: twenty-five years of experience in a single center. Perit Dial Int 29: 492-498, 2009
183. Huang ST, Chuang YW, Cheng CH,Wu MJ, Chen CH, Yu TM, Shu KH: Evolution of microbiological trends and treatment outcomes in peritoneal dialysis-related peritonitis. Clin Nephrol 75: 416-425, 2011
184. Rocha A, Rodrigues A, Teixeira L, Carvalho MJ, Mendona D, Cabrita A: Temporal trends in peritonitis rates,microbiology and outcomes: the major clinical complication of peritoneal dialysis. Blood Purif 33: 284-291, 2012
185. Ozisik L, Ozdemir FN, Tanriover MD: The changing trends of peritoneal dialysis related peritonitis and novel risk factors. Ren Fail 37: 1027-1032, 2015
186. Kiernan L, Kliger A, Gorban-Brennan N, Juergensen P, Tesin D, Vonesh E, Finkelstein F: Comparison of continuous ambulatory peritoneal dialysis-related infections with different "Y-tubing" exchange systems. J Am Soc Nephrol 5: 1835-1838, 1995
187. LoWK, Chan CY, Cheng SW, Poon JF, Chan DT, Cheng IK: A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis. Am J Kidney Dis 28: 549-552, 1996
188. Thodis E, Bhaskaran S, Pasadakis P, Bargman JM, Vas SI, Oreopoulos DG: Decrease in Staphylococcus aureus exitsite infections and peritonitis in CAPD patients by local application of mupirocin ointment at the catheter exit site. Perit Dial Int 18: 261-270, 1998
189. Bernardini J, Bender F, Florio T, Sloand J, Palmmontalbano L, Fried L, Piraino B: Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 16: 539-545, 2005
190. Troidle L, Finkelstein F: Treatment and outcome of CPD-associated peritonitis. Ann Clin Microbiol Antimicrob 5: 6, 2006
191. Gadola L, Poggi C, Poggio M, Sáez L, Ferrari A, Romero J, Fumero S, Ghelfi G, Chifflet L, Borges PL: Using a multidisciplinary training program to reduce peritonitis in peritoneal dialysis patients. PeritDial Int 33: 38-45, 2013
192. Zhang L, Hawley CM, Johnson DW: Focus on peritoneal dialysis training: working to decrease peritonitis rates. Nephrol Dial Transplant 31: 214-222, 2016
193. Schaepe C, Bergjan M: Educational interventions in peritoneal dialysis: a narrative review of the literature. Int J Nurs Stud 52: 882-898, 2015
194. Registry ANZDATA: 37th Report, Chapter 5, Adelaide, Australia, Peritoneal Dialysis, Australia and New Zealand Dialysis and Transplant Registry, 2015
195. Jose MD, Johnson DW, Mudge DW, Tranaeus A, Voss D, Walker R, Bannister KM: Peritoneal dialysis practice in Australia and New Zealand: a call to action. Nephrology (Carlton) 16: 19-29, 2011
196. Johnson DW, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, de Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM; HONEYPOT Study Collaborative Group: Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial. Lancet Infect Dis 14: 23-30, 2014
197. Campbell DJ, Brown FG, Craig JC, Gallagher MP, JohnsonDW,KirklandGS, Kumar SK, Lim WH, Ranganathan D, Saweirs W, Sud K, Toussaint ND, Walker RG, Williams LA, Yehia M, Mudge DW: Assessment of current practice and barriers to antimicrobial prophylaxis in peritoneal dialysis patients. Nephrol Dial Transplant 31: 619-627, 2016
198. Walker A, Bannister K, George C, Mudge D, Yehia M, Lonergan M, Chow J: KHA-CARI Guideline: peritonitis treatment and prophylaxis. Nephrology (Carlton) 19: 69-71, 2014
199. Zhang L, Badve SV, Pascoe EM, Beller E, Cass A, Clark C, De Zoysa J, Isbel NM, McTaggart S, Morrish AT, Playford EG, Scaria A, Snelling P, Vergara LA, Hawley CM, Johnson DW, Honeypot Study Collaborative: Microbiological results of the HONEYPOT study - secondary analysis of a randomised, controlled trial of exit site application of medihoney for the prevention of catheter-associated infections in PD patients. Nephrology (Carlton) 19: 30, 2014
200. Piraino B, Bernardini J, Brown E, Figueiredo A, Johnson DW, Lye WC, Price V, Ramalakshmi S, Szeto CC: ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int 31: 614-630, 2011
201. Kopriva-Altfahrt G, König P, Mündle M, Prischl F, Roob JM, Wiesholzer M, Vychytil A, Arneitz K, Karner A, Artes R, Wolf E, Auinger M, Pawlak A, Fraberger J, Hofbauer S, Galvan G, Salmhofer H, Pichler B, Wazel M, Gruber M, Thonhofer A, Hager A, Malajner S, Heiss S, Braunsteiner T, Zweiffler M, König P, Rudnicki M, Kogler R, Kohlhauser D, Wiesinger T, Kopriva-Altfahrt G, Moser E, Kotanko P, Loibner H, Nitz H, Miska HJ, Wenzel R, Wölfer M, Mündle M, Breuss H, Hölzl B, Prischi F, Schmekal B, Riener EM, Roob JM, Wonisch W, Vikydal R, Vychytil A, Frank B, Wieser C, Wiesholzer M, Pokorny K; Austrian Study Group for Prevention of Peritoneal Catheter-Associated Infections: Exit-site care in Austrian peritoneal dialysis centers - a nationwide survey. Perit Dial Int 29: 330-339, 2009
202. Kavanagh D, Prescott GJ, Mactier RA: Peritoneal dialysis-associated peritonitis in Scotland (1999-2002). Nephrol Dial Transplant 19: 2584-2591, 2004
203. Davenport A: Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int 29: 297-302, 2009
204. Martin LC, Caramori JC, Fernandes N, Divino-Filho JC, Pecoits-Filho R, Barretti P; Brazilian Peritoneal Dialysis Multicenter Study BRAZPD Group: Geographic and educational factors and risk of the first peritonitis episode in Brazilian Peritoneal Dialysis study (BRAZPD) patients. Clin J Am Soc Nephrol 6: 1944-1951, 2011
205. Figueiredo AE, Moraes TP, Bernardini J, Poli-de-Figueiredo CE, Barretti P, Olandoski M, Pecoits-Filho R; BRAZPD Investigators: Impact of patient training patterns on peritonitis rates in a large national cohort study. Nephrol Dial Transplant 30: 137-142, 2015
206. Badve SV, Smith A, Hawley CM, Johnson DW: Adherence to guideline recommendations for infection prophylaxis in peritoneal dialysis patients.NDT Plus 2: 508, 2009
207. Nadeau-FredetteAC, JohnsonDW, Hawley CM, Pascoe E, Cho Y, Clayton PA, Borlace M, Badve SV, Sud K, Boudville N, McDonald SP: Centre-specific factors associated with peritonitis risk - a multi-center registry analysis [published online ahead of print, January 13, 2016. Perit Dial Int doi: 10.3747/pdi.2015.00146
208. Li PK, Szeto CC, Piraino B, Bernardini J, Figueiredo AE, Gupta A, Johnson DW, Kuijper EJ, Lye WC, Salzer W, Schaefer F, Struijk DG; International Society for Peritoneal Dialysis: Peritoneal dialysis-related infections recommendations: 2010 update. Perit Dial Int 30: 393-423, 2010